About the share | KDventures

About us
About KD Ventures

KDventures invests in life science companies developing potentially groundbreaking treatments to alleviate or cure serious diseases.
About KDventures
Navigation

Careers

Sustainability

Our investment philosophy

Employees

KDventures as an investment
Careers at KDventures

Do you want to work at the intersection of life science, investments and company building? With us, you will be part of a specialist team working closely with innovative companies and the treatments of the future.
Our portfolio
Our portfolio

KDventures has a focused portfolio consisting of pharmaceutical and medical technology companies with significant value-creation potential.
Go to the portfolio
Navigation

Current & former companies

Our investment philosophy
Dilafor

KDventures has supported Dilafor from early development to a global partnership with Exeltis, which is funding the continued Phase 3 development of tafoxiparin.
Investors
For investors

Through active ownership, specialist expertise and a portfolio with clear value drivers, we provide our shareholders with exposure to long-term value creation in life science.
For investors
The share & ownership

The share

Our shareholders

Insider ownership

Insider transactions

Company information

Analysts
Financials & Press Releases

Press releases

Reports & presentations

Financial key figures

Presentations

Financial calendar

IPO
Corporate governance

Articles of association

Corporate governance

General meetings

Policy

Board committees

Nomination committee

Incentive programme
Investment philosophy
Contact

KDventures' Class B share is listed on Nasdaq Stockholm. Here you can find the current share price, historical price performance, trading information and relevant key data for shareholders and investors.

This website uses cookiesfor statistics and user experience.

Shares

Subscribe to KD Ventures